IPO Price History
Closed
Eris Lifesciences Limited logo

Eris Lifesciences Limited IPO

Mainboard IPOListedERISNSE
Current Market Price (CMP)
₹1,095.50(+81.67%)
Current Price (CMP)
₹1,095.50(+81.67%)

Live Market Quote

Listing Price & Gain
₹611(+1.33%)

Day 1 Exchange Open

IPO Issue Price
₹603

Band: ₹600 - ₹603

Total Subscription
3.29x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
16 Jun 2017
IPO Bidding Closes
20 Jun 2017
Allotment & Refunds
Completed
Exchange Listing Day
29 Jun 2017

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 3.29x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)4.68x
Non-Institutional Investors (NII / HNI)0.45x
Retail Individual Investors (RII)0.86x
Total Subscription3.29x
Updated as on 20th Jun 2017 at 2030 hrs

Listing Day & Return Performance

Listing Day Gain+1.33%
₹603 (Issue) → ₹611 (List)
Per share profit: +₹8.00
Holding Return (Till Date)+81.67%
₹603 (Issue) → ₹1,095.50 (CMP)
Net gain per share: +₹492.50
Post-Listing Performance (Listing Day → Today):+79.30%

About Eris Lifesciences Limited IPO

Eris Lifesciences Limited is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 16 Jun 2017 and concluded on 20 Jun 2017, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹600 - ₹603.

During the bidding window, Eris Lifesciences Limited recorded an overall subscription of 3.29 times. Institutional investors (QIB) subscribed 4.68x, non-institutional high-net-worth investors (NII) subscribed 0.45x, and retail individual investors (RII) bid 0.86x their reserved quota.

The equity shares of Eris Lifesciences Limited officially debuted on the stock exchanges on 29 Jun 2017 at an opening listing price of ₹611, delivering a listing day return of +1.33% (premium) over the final issue price. As per the latest market data, the stock trades at ₹1,095.50, representing an overall gain of +81.67% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Eris Lifesciences Limited IPO?
The issue price of Eris Lifesciences Limited IPO was fixed at ₹603 per equity share. The indicative bidding price band was ₹600 - ₹603.
What were the open, close, and listing dates for Eris Lifesciences Limited IPO?
Eris Lifesciences Limited IPO opened on 16 Jun 2017, closed on 20 Jun 2017, listed on 29 Jun 2017.
How much was Eris Lifesciences Limited IPO subscribed?
The IPO received an overall subscription of 3.29 times. Category-wise, QIBs subscribed 4.68x, NIIs subscribed 0.45x, and Retail investors subscribed 0.86x.
What was the listing price and listing gain of Eris Lifesciences Limited IPO?
Eris Lifesciences Limited IPO listed on the stock exchange at ₹611, delivering a listing gain of 1.33% compared to the IPO issue price of ₹603.
Is Eris Lifesciences Limited IPO a Mainboard or SME IPO?
Eris Lifesciences Limited IPO is a Mainboard IPO listed on the main exchange of NSE.
What is the current return of Eris Lifesciences Limited IPO since its IPO?
At the latest market quote of ₹1,095.50, Eris Lifesciences Limited IPO has generated an all-time return of +81.67% since its initial public offering.

Related Mainboard IPOs (2017)

ASTRON
Astron Paper & Board Mills Limited
₹50+130.00%
FSC
Future Supply Chain Solutions Limited
₹664Unlisted
SHALBY
Shalby Limited
₹248-3.35%
HDFCLIFE
HDFC Standard Life Insurance Company Limited
₹290+6.90%